NIFTY 500 › Fast Moving Consumer Goods
Overview Technical Risk & rank Quality Results Accounts Filings Options Guidance & governance
Filings
30 filings of COLPAL since November 2024.
board outcome 14, presentation 5, transcript 5, dividend 4, results 2
| Filed | Type | Subject | |
|---|---|---|---|
| 22 Oct 2026 | board outcome Dividend / buy-back, Management change, Results | Colgate Palmolive (India) Limited has informed the Exchange regarding Outcome of Board Meeting held on October 22, 2026.AI summaryBoard outcome filing: approved unaudited results for Q2 and half year ended September 30, 2026; Q2 net profit Rs 34,157 lakhs and revenue from operations (sales) Rs 1,69,157 lakhs. Declared first interim dividend of Rs 24 per equity share of Re 1 each for FY 2026-27, payable from November 19, 2026, with record date November 2, 2026. Appointed Ms. Ragini Gajaria as Internal Auditor effective October 22, 2026. Noted resignation of Mr. Gunjit Jain as Executive Vice President - Marketing effective close of business November 30, 2026; approved appointment of Mr. Akash Parekh as Executive Vice President - Marketing effective December 1, 2026. Board to seek member approval via postal ballot for appointment of Mr. Manish Anandani (DIN 07257875) as Managing Director & CEO. Written by an AI model (claude-haiku-5-5) from the filing's first pages; it can be wrong - the filing is the source. | NSE copy |
| 22 Oct 2026 | board outcome Dividend / buy-back, Management change, Results | Colgate Palmolive (India) Limited has informed the Exchange regarding Outcome of Board Meeting held on October 22, 2026.AI summaryBoard outcome filing: approved unaudited results for quarter and half year ended September 30, 2026; Q2 net profit Rs 34,157 lakhs against Rs 32,751 lakhs in the year-ago quarter, and half-year net profit Rs 68,465 lakhs against Rs 64,813 lakhs. Q2 revenue from operations (sales) was Rs 1,69,157 lakhs; total income Rs 1,73,150 lakhs (as printed in the table). Declared first interim dividend of Rs 24 per equity share of Re 1 each for FY 2026-27, payable from November 19, 2026, with record date November 2, 2026. Appointed Ms. Ragini Gajaria as Internal Auditor effective October 22, 2026; noted resignation of Mr. Gunjit Jain as Executive Vice President - Marketing effective close of business November 30, 2026. Approved appointment of Mr. Akash Parekh as Executive Vice President - Marketing effective December 1, 2026; Managing Director & CEO appointment of Mr. Manish Anandani to be sought via postal ballot. Written by an AI model (claude-haiku-5-5) from the filing's first pages; it can be wrong - the filing is the source. | NSE copy |
| 22 Oct 2026 | dividend Dividend / buy-back, Management change, Results | Colgate Palmolive (India) Limited has informed the Exchange that Board of Directors at its meeting held on October 22, 2026, declared Interim Dividend of Rs. 24 per equity share.AI summaryColgate-Palmolive (India) filed the outcome of its October 22, 2026 board meeting, which approved unaudited results for the quarter and half year ended September 30, 2026. Q2 FY27 sales were Rs 1,69,157 lakhs and net profit was Rs 34,157 lakhs, against Rs 32,751 lakhs in the year-ago quarter; half-year net profit was Rs 68,465 lakhs. The board declared a First Interim Dividend of Rs 24 per equity share of Re 1 each for FY 2026-27, payable from November 19, 2026, with record date November 2, 2026. The board appointed Ms. Ragini Gajaria as Internal Auditor, noted the resignation of Mr. Gunjit Jain as Executive Vice President - Marketing effective November 30, 2026, and approved Mr. Akash Parekh as Executive Vice President - Marketing effective December 1, 2026. A postal ballot is to seek member approval for Mr. Manish Anandani's appointment as Managing Director & CEO. Written by an AI model (claude-haiku-5-5) from the filing's first pages; it can be wrong - the filing is the source. | NSE copy |
| 22 Oct 2026 | board outcome Dividend / buy-back, Management change, Results | Colgate Palmolive (India) Limited has informed the Exchange that Board of Directors at its meeting held on October 22, 2026, approved Financial ResultsAI summaryColgate-Palmolive (India) filed the outcome of its October 22, 2026 board meeting, which approved unaudited results for the quarter and half year ended September 30, 2026. Q2 FY27 sales were Rs 1,69,157 lakhs and net profit was Rs 34,157 lakhs, against Rs 32,751 lakhs in the year-ago quarter; half-year net profit was Rs 68,465 lakhs. The board declared a first interim dividend of Rs 24 per equity share of Re 1 each for FY 2026-27, payable on and from November 19, 2026, with record date November 2, 2026. The board appointed Ms. Ragini Gajaria as Internal Auditor, noted the resignation of Mr. Gunjit Jain as Executive Vice President - Marketing effective November 30, 2026, and approved Mr. Akash Parekh as Executive Vice President - Marketing effective December 1, 2026. Member approval by postal ballot will be sought for the appointment of Mr. Manish Anandani as Managing Director & CEO; the cut-off date is October 23, 2026. Written by an AI model (claude-haiku-5-5) from the filing's first pages; it can be wrong - the filing is the source. | NSE copy |
| 28 Sep 2026 | board outcome Management change | Colgate Palmolive (India) Limited has informed the Exchange regarding Outcome of Board Meeting held on September 28, 2026.AI summaryBoard of Colgate-Palmolive (India) Limited at its meeting on September 28, 2026 noted the resignation of Mr. Priyan Pillay as Executive Vice President - Legal, effective close of business October 23, 2026, to pursue an opportunity outside the company. The Board approved, on NRC recommendation, the appointment of Mr. Abhijit Yadav, currently Legal Director, as Executive Vice President - Legal, effective October 24, 2026, in succession to Mr. Pillay. Mr. Yadav has been with the company since 2019 as Legal Director and previously held senior legal roles at Marico Limited, L'Oréal India and Sanofi India Limited. The board meeting commenced at 4:45 p.m. IST and concluded at 5:00 p.m. IST. Written by an AI model (claude-haiku-5-5) from the filing's first pages; it can be wrong - the filing is the source. | NSE copy |
| 21 Aug 2026 | transcript | Colgate Palmolive (India) Limited has informed the Exchange about TranscriptAI summaryColgate-Palmolive (India) filed the transcript of its Investor Day 2026, held on August 17, 2026, under Regulation 30 of the SEBI Listing Regulations. Managing Director and CEO Prabha Narasimhan said urban toothpaste users brushing twice a day fell from 80% to 76%, and rural users not brushing daily fell from 55% to 45%. Narasimhan said toothpaste premiumisation rose from 14.8% to 18.6% over the last three years, and that Colgate is the most distributed toothpaste brand, reaching 1.7 million outlets directly and 7.1 million in total. Narasimhan said the company's strategy has been consistent for just over three years: grow toothpaste category consumption, expand premium toothpaste, lead toothbrush category growth and build personal care. The transcript covers the oral care category and strategy; the financial performance section was not included in the pages provided. Written by an AI model (claude-haiku-5-5) from the filing's first pages; it can be wrong - the filing is the source. | NSE copy |
| 21 Aug 2026 | board outcome Management change | Outcome of the Board Meeting - Change in the MD & CEOAI summaryColgate-Palmolive (India) filed the outcome of its board meeting held on August 21, 2026 (8:00 a.m. to 8:45 a.m. IST). Board noted the resignation of Ms. Prabha Narasimhan as Managing Director and CEO, effective close of business on September 27, 2026, on her promotion to Executive Vice President - Marketing, Asia-Pacific Division of Colgate-Palmolive. On NRC recommendation, the board approved appointment of Mr. Manish Anandani as Managing Director and CEO for five years, effective September 28, 2026 (term to September 27, 2031), subject to shareholder and other statutory approvals. Mr. Anandani was previously Managing Director for India and South Asia at Kenvue and had earlier worked at Colgate-Palmolive from 2005 to 2018. Written by an AI model (claude-haiku-5-5) from the filing's first pages; it can be wrong - the filing is the source. | NSE copy |
| 17 Aug 2026 | presentation | Colgate Palmolive (India) Limited has informed the Exchange about Investor PresentationAI summaryColgate-Palmolive (India) filed an investor presentation ahead of its Investor Day 2026 analyst conference call, held on August 17, 2026 at 5:00 PM IST. The presentation is available on the company website at colgateinvestors.co.in/presentation-to-analysts. The visible slides cover the company's mission to help people improve oral health and beauty, and oral health awareness gaps in India (for example, 55% gum problem incidence versus 13% realization, and 80% cavities incidence versus 10% realization, per Mouth Audit 2023 and Kantar Dental Camp Study 2019). The slides also cite systemic health and habit impacts on oral health, such as diabetes at 2.7X gum issues risk and tobacco at 13.7X stains risk (Colgate OHM Internal Data). The filed pages do not include financial figures, guidance or management commentary on performance. Written by an AI model (claude-haiku-5-5) from the filing's first pages; it can be wrong - the filing is the source. | NSE copy |
| 29 Jul 2026 | board outcome Results | Colgate Palmolive (India) Limited has submitted to the Exchange, the financial results for the period ended Jun 30, 2026.AI summaryColgate-Palmolive (India) Limited's board approved the unaudited financial results for the quarter ended June 30, 2026 at a meeting held on July 29, 2026 (10:30 a.m. to 11:30 a.m. IST). Q1 FY27 sales were Rs. 1,59,056 lakhs, against Rs. 1,42,064 lakhs in the quarter ended June 30, 2025. Total income for the quarter was Rs. 1,62,610 lakhs, against Rs. 1,45,200 lakhs a year earlier. Net profit for the quarter was Rs. 34,308 lakhs, against Rs. 32,062 lakhs a year earlier. Basic and diluted earnings per share (face value Re 1) were Rs. 12.61, against Rs. 11.79 a year earlier. Written by an AI model (claude-haiku-5-5) from the filing's first pages; it can be wrong - the filing is the source. | NSE copy |
| 28 May 2026 | transcript Results | Colgate Palmolive (India) Limited has informed the Exchange about TranscriptAI summaryColgate-Palmolive (India) filed the transcript of its analyst conference call held on May 22, 2026 on results for Q4 and FY ended March 31, 2026. Management said Q4 net sales were Rs. 1,583 crores, up 9% year-on-year, with domestic growth at 9.2%; NPAT was Rs. 353 crores, and excluding a one-off, NPAT growth was in line with top-line growth. Management said full-year growth was flat, with the second half growing a shade over 5%; gross margin was 69.6% and EBITDA margin a shade over 32% in Q4, with brand investments just under Rs. 200 crores. Management said it is focused on driving consumption, Premiumization (Colgate Total, Visible White, PerioGard) and toothbrushes, and expressed renewed optimism and confidence for calendar year 2026. Written by an AI model (claude-haiku-5-5) from the filing's first pages; it can be wrong - the filing is the source. | NSE copy |
| 22 May 2026 | presentation Results | Colgate Palmolive (India) Limited has informed the Exchange about Investor PresentationAI summaryColgate-Palmolive (India) filed an analyst meet presentation ahead of its analyst conference call on May 22, 2026 at 5:30 PM IST, covering Q4 and FY2026 results. Q4 FY26: net sales ₹1,583 crore, up 9.0% y-o-y; domestic net sales growth +9.2%; EBITDA margin 32.2%; gross margin 69.6%; NPAT ₹353 crore, up 9.2% y-o-y; brand investments ₹199 crore (12.6% of net sales). FY26: net sales ₹5,984 crore, flat y-o-y; NPAT ₹1,325 crore, down 1.8% y-o-y; EBITDA margin 31.2%; gross margin 69.3%; brand investments ₹819 crore (13.7% of net sales). Management said net sales growth accelerated in Q4 FY26, with a sharp recovery in H2 FY26 net sales growth of +5.2%, and that margins remain resilient and superior to peers. Management highlighted continued focus on consumption, accelerated investment in premiumisation and a strong foundation for consistent long-term growth. Written by an AI model (claude-haiku-5-5) from the filing's first pages; it can be wrong - the filing is the source. | NSE copy |
| 22 May 2026 | dividend Dividend / buy-back, Management change, Results | Colgate Palmolive (India) Limited has informed the Exchange that Board of Directors at its meeting held on May 22, 2026, declared Interim Dividend of Rs. 24 per equity share.AI summaryThe Board of Colgate-Palmolive (India) Limited approved audited financial results for the fourth quarter and financial year ended March 31, 2026, with an unmodified audit opinion from statutory auditors SRBC & Co LLP. The Board declared a second interim dividend of Rs. 24 per equity share of Re. 1 each for FY 2025-26, with a record date of June 1, 2026 and payment on or from June 17, 2026. The 85th AGM is to be held on July 29, 2026 via VC/OAVM; the register of members will be closed from July 23, 2026 to July 29, 2026 (both days inclusive). The Board approved the re-appointment of Mr. Jacob Sebastian Madukkakuzy as Whole-time Director & CFO for five years from October 28, 2026 to October 27, 2031, subject to shareholder approval. Written by an AI model (claude-haiku-5-5) from the filing's first pages; it can be wrong - the filing is the source. | NSE copy |
| 22 May 2026 | board outcome Dividend / buy-back, Management change, Results | Colgate Palmolive (India) Limited has submitted to the Exchange, the financial results for the period ended March 31, 2026.AI summaryBoard approved audited financial results for Q4 and financial year ended March 31, 2026, with unmodified auditor opinion from SRBC & Co LLP. Board declared second interim dividend of Rs. 24 per equity share of Re. 1 each for FY 2025-26; record date June 1, 2026; payment from June 17, 2026. Board approved convening the 85th AGM on July 29, 2026 via VC/OAVM; register of members closed July 23 to July 29, 2026 (both inclusive). Board approved re-appointment of Mr. Jacob Sebastian Madukkakuzy as Whole-time Director & CFO for 5 years from October 28, 2026 to October 27, 2031, subject to shareholder approval. Written by an AI model (claude-haiku-5-5) from the filing's first pages; it can be wrong - the filing is the source. | NSE copy |
| 29 Jan 2026 | board outcome Results | Colgate Palmolive (India) Limited has submitted to the Exchange, the financial results for the period ended December 31, 2025.AI summaryColgate-Palmolive (India) Limited's board approved the unaudited financial results for the quarter and nine months ended December 31, 2025 at a meeting held on January 29, 2026 (4:45 p.m. to 6:00 p.m. IST). Q3 FY26 (quarter ended Dec 31, 2025) sales were Rs. 1,47,292 lakhs and net profit was Rs. 32,386 lakhs, with basic and diluted EPS of Rs. 11.91 (face value Re 1). Nine months ended Dec 31, 2025: sales were Rs. 4,40,080 lakhs (vs Rs. 4,54,718 lakhs a year earlier), net profit Rs. 97,199 lakhs (vs Rs. 1,08,181 lakhs), and EPS Rs. 35.74 (vs Rs. 39.77). The quarter includes an exceptional expense of Rs. 839 lakhs. Written by an AI model (claude-haiku-5-5) from the filing's first pages; it can be wrong - the filing is the source. | NSE copy |
| 26 Nov 2025 | board outcome Management change | Colgate Palmolive (India) Limited has informed the Exchange regarding Board meeting held on November 26, 2025.AI summaryColgate-Palmolive (India) filed the outcome of its board meeting held on November 26, 2025 (Regulation 30 SEBI LODR), which ran from 9:30 a.m. to 10:00 a.m. IST. The board approved, on NRC recommendation, the appointment of Mr. Priyan Pillay as Executive Vice-President - Legal (Senior Management Personnel) effective January 2, 2026. The board approved the appointment of Mr. Jaikishan Shah as Company Secretary and Compliance Officer (Key Managerial Personnel) effective November 26, 2025. Mr. Pillay is Chief Compliance Counsel at Colgate-Palmolive Company, New York, with over 19 years of experience; Mr. Shah is currently Deputy Company Secretary & Manager - Legal and Compliance Officer at the company, with over 14 years of experience. Written by an AI model (claude-haiku-5-5) from the filing's first pages; it can be wrong - the filing is the source. | NSE copy |
| 23 Oct 2025 | dividend Dividend / buy-back, Management change, Results | Colgate Palmolive (India) Limited has informed the Exchange that Board of Directors at its meeting held on October 23, 2025, declared Interim Dividend of Rs. 24 per equity share.AI summaryColgate-Palmolive (India) Limited's board approved unaudited financial results for the quarter and half year ended September 30, 2025 on October 23, 2025. Q2 FY26 revenue from operations (sales) was Rs. 1,50,724 lakhs, against Rs. 1,60,921 lakhs in Q2 FY25; Q2 net profit was Rs. 32,751 lakhs, against Rs. 39,505 lakhs a year earlier. Half-year FY26 net profit was Rs. 64,813 lakhs, against Rs. 75,903 lakhs in H1 FY25; basic and diluted EPS for the half year was Rs. 23.83. The board declared a first interim dividend of Rs. 24 per equity share of face value Re. 1, payable from November 19, 2025 to shareholders on the record date of November 03, 2025. Surender Sharma ceased as Whole-time Director - Legal & Company Secretary effective close of business October 27, 2025; Jaikishan Shah was appointed Compliance Officer effective October 28, 2025. Written by an AI model (claude-haiku-5-5) from the filing's first pages; it can be wrong - the filing is the source. | NSE copy |
| 23 Oct 2025 | board outcome Dividend / buy-back, Legal, Management change, Results | Colgate Palmolive (India) Limited has submitted to the Exchange, the financial results for the period ended September 30, 2025.AI summaryColgate-Palmolive (India) reported unaudited results for the quarter and six months ended September 30, 2025: Q2 FY26 sales of Rs. 1,50,724 lakhs (vs Rs. 1,60,921 lakhs in Q2 FY25), net profit of Rs. 32,751 lakhs (vs Rs. 39,505 lakhs) and basic and diluted EPS of Rs. 12.04. Six-month net profit was Rs. 64,813 lakhs (vs Rs. 75,903 lakhs) and six-month sales were Rs. 2,92,788 lakhs (vs Rs. 3,09,497 lakhs). The Board declared a first interim dividend of Rs. 24 per equity share of face value Re. 1 for FY 2025-26, payable from November 19, 2025 to shareholders on the record date of November 03, 2025. Sumit Narasimhan... Surender Sharma ceased as Whole-time Director - Legal & Company Secretary effective close of business October 27, 2025; Jaikishan Shah was appointed Compliance Officer effective October 28, 2025. The Board also approved a revision to the Policy on Determination of Materiality of Event or Information. Written by an AI model (claude-haiku-5-5) from the filing's first pages; it can be wrong - the filing is the source. | NSE copy |
| 22 Jul 2025 | board outcome Results | Colgate Palmolive (India) Limited has submitted to the Exchange, the financial results for the period ended Jun 30, 2025.AI summaryColgate-Palmolive (India) Limited filed the outcome of its board meeting held on July 22, 2025, approving unaudited financial results for the first quarter ended June 30, 2025, with a limited review report from the auditors. Quarter ended June 30, 2025: Revenue from operations (sales) Rs 1,42,064 lakhs versus Rs 1,48,576 lakhs in the quarter ended June 30, 2024; total income Rs 1,45,200 lakhs versus Rs 1,52,011 lakhs. Net profit for the quarter was Rs 32,062 lakhs, compared with Rs 36,398 lakhs in the quarter ended June 30, 2024. Basic and diluted earnings per share (face value Re 1) were Rs 11.79, compared with Rs 13.38 in the year-earlier quarter. The board meeting ran from 11:50 a.m. to 12:45 p.m. IST. Written by an AI model (claude-haiku-5-5) from the filing's first pages; it can be wrong - the filing is the source. | NSE copy |
| 28 May 2025 | transcript Results | Colgate Palmolive (India) Limited has informed the Exchange about TranscriptAI summaryColgate-Palmolive India's FY2024-25 analyst call (22 May 2025), management said full-year revenue was Rs. 5,999 crores, up 6.3%, with EBITDA margin of 32.6% and gross margin of 69.7%. Management said brand investment on the Colgate brand was Rs. 822 crores in the year and advertising rose 13.7% for the full year, and full-year profit after tax rose 8.5%. Management said Q4 revenue was Rs. 1,452 crores, down 1.9% year-on-year, and that margins were supported by cost management rather than price increases. Management said urban category growth had softened significantly while rural growth outpaced urban for a third straight quarter. Written by an AI model (claude-haiku-5-5) from the filing's first pages; it can be wrong - the filing is the source. | NSE copy |
| 28 May 2025 | transcript | Colgate Palmolive (India) Limited has informed the Exchange about TranscriptAI summaryColgate-Palmolive (India) filed the transcript of its analyst conference call on Q4 and FY2025 financial results (quarter and year ended March 31, 2025), held on May 22, 2025. The filing is made under Regulation 30 of the SEBI Listing Obligations and Disclosure Requirements Regulations, 2015. The transcript is also available on the company website at colgateinvestors.co.in. The cover letter does not contain the management remarks or figures from the call. Written by an AI model (claude-haiku-5-5) from the filing's first pages; it can be wrong - the filing is the source. | NSE copy |
| 22 May 2025 | presentation Results | Colgate Palmolive (India) Limited has informed the Exchange about Investor PresentationAI summaryColgate-Palmolive (India) filed the investor presentation for its analyst conference call on Q4 and FY25 results, held on May 22, 2025 at 11 a.m. IST. FY25 net sales were ₹5,999 crore, up 6.3% y-o-y; net profit after tax (NPAT) was ₹1,437 crore, up 8.5% y-o-y. FY25 gross margin was 69.7% and EBITDA margin was 32.6%. Brand investments (advertising) were ₹822 crore, 13.7% of net sales; domestic topline growth was 5.6%. Management stated "We continue to win" and cited strong brand health in 2024 and Q1'25 per Kantar data. Written by an AI model (claude-haiku-5-5) from the filing's first pages; it can be wrong - the filing is the source. | NSE copy |
| 21 May 2025 | dividend Dividend / buy-back, Legal, Results | Colgate Palmolive (India) Limited has informed the Exchange that Board of Directors at its meeting held on May 21, 2025, declared Interim Dividend of Rs. 27 per equity share.AI summaryColgate-Palmolive (India) Limited filed the outcome of its Board meeting held on May 21, 2025, approving audited financial results for Q4 and financial year ended March 31, 2025, with an unmodified audit report from SRBC & Co LLP. The Board declared a second interim dividend of Rs. 27 per equity share of Re. 1 each for FY 2024-25, payable from June 16, 2025 to shareholders on the record date of May 28, 2025. The Board approved convening the 84th AGM on July 22, 2025 via VC/OAVM; the register of members will be closed from July 16, 2025 to July 22, 2025 (both inclusive). The Board approved appointing Dholakia & Associates LLP as Secretarial Auditors for five years from FY 2025-26 to FY 2029-30, subject to shareholder approval, and approved revisions to its Related Party Transactions Policy, Insider Trading Code of Conduct and materiality policy. Written by an AI model (claude-haiku-5-5) from the filing's first pages; it can be wrong - the filing is the source. | NSE copy |
| 21 May 2025 | board outcome Dividend / buy-back, Legal, Results | Colgate Palmolive (India) Limited has submitted to the Exchange, the financial results for the period ended March 31, 2025.AI summaryColgate-Palmolive (India) filed the outcome of its May 21, 2025 board meeting, which approved audited financial results for the fourth quarter and financial year ended March 31, 2025, with an unmodified audit report from statutory auditors SRBC & Co LLP. The board declared a second interim dividend of Rs. 27 per equity share of Re. 1 each for FY 2024-25, payable from June 16, 2025 to shareholders on the record date of May 28, 2025. The board approved convening the 84th AGM on July 22, 2025 via video conference/other audio-visual means; the register of members will be closed from July 16, 2025 to July 22, 2025. The board approved appointing Dholakia & Associates LLP as Secretarial Auditors for five years from FY 2025-26 to FY 2029-30, subject to shareholder approval. The board also approved revisions to its Related Party Transactions Policy, Insider Trading Code of Conduct, and Policy on determination of Materiality of Event or Information. Written by an AI model (claude-haiku-5-5) from the filing's first pages; it can be wrong - the filing is the source. | NSE copy |
| 17 Mar 2025 | board outcome Management change | Colgate Palmolive (India) Limited has informed the Exchange regarding Board meeting held on March 17, 2025.AI summaryColgate-Palmolive (India) Limited filed the outcome of its board meeting held on March 17, 2025 (meeting ran 10:45 a.m. to 11.50 a.m.). The board, on Nomination and Remuneration Committee recommendation and subject to member approval by postal ballot, approved re-appointment of Ms. Gopika Pant as Non-Executive Independent Director for a second 5-year term from May 21, 2025 to May 20, 2030. Mr. Sekhar Natarajan is re-appointed as Non-Executive Independent Director for a second term from May 21, 2025 to December 13, 2028, when he reaches age 75. Mr. Surender Sharma is re-appointed as Whole-time Director for 5 years from May 21, 2025 to May 20, 2030. The postal ballot cut-off date is March 21, 2025. Written by an AI model (claude-haiku-5-5) from the filing's first pages; it can be wrong - the filing is the source. | NSE copy |
| 21 Feb 2025 | presentation Guidance | Colgate Palmolive (India) Limited has informed the Exchange about Investor PresentationAI summaryColgate-Palmolive (India) filed the presentation for its investor/analyst meet held on February 21, 2025 at 08:00 a.m. (EST), also posted on the company website. Presentation points by management: the company shifted its marketing and innovation strategy back towards science-led, core and premium innovation, aims to expand brushing occasions to increase consumption, and significantly increased advertising spend. Management describes India as a country with tremendous potential, citing estimated GDP growth of ~6.5-7.0% for 2025-30, about 200M high and upper-middle income households by 2030, and modern trade plus eCommerce expected at 34% of overall retail by 2030. Management describes CP India as a fundamentally strong business: #1 oral care brand, ~$8B market capitalization (as of Feb 2025), 24% CAGR shareholder return over 45 years, 2.8X share of market versus the #2 brand, 95% weighted distribution and 7M stores with Colgate availability. Written by an AI model (claude-haiku-5-5) from the filing's first pages; it can be wrong - the filing is the source. | NSE copy |
| 28 Jan 2025 | results Results | Please find enclosed herewith Integrated Filing (Financial) for the quarter ended December 31, 2024AI summaryColgate-Palmolive (India) Limited filed its Integrated Filing (Financial) for the quarter and nine months ended December 31, 2024, with BSE and NSE, under SEBI Circular SEBI/HO/CFD/CFD-PoD-2/CIR/P/2024/185 dated December 31, 2024. The filing is signed by Surender Sharma, Whole-time Director – Legal & Company Secretary. The pages provided show only the cover letter and section headings; the financial figures themselves are not included in the text. Sections B, C, D and E (public issue proceeds, loan defaults, related party transactions, audit qualifications) are marked Not Applicable. Written by an AI model (claude-haiku-5-5) from the filing's first pages; it can be wrong - the filing is the source. | NSE copy |
| 28 Jan 2025 | results Results | Colgate Palmolive (India) Limited has submitted to the Exchange, the financial results for the period ended December 31, 2024.AI summaryBoard approved the unaudited financial results for the third quarter and nine months ended December 31, 2024, meeting held January 28, 2025 (2:22 p.m. to 3:45 p.m. IST). Q3 FY25 net sales were Rs. 1,452 crore, up 4.7% year-on-year; nine-month net sales were Rs. 4,547 crore, up 9.2% from Rs. 4,164 crore. Q3 FY25 net profit after tax was Rs. 322.8 crore versus Rs. 330.1 crore a year earlier; nine-month net profit after tax was Rs. 1,081.8 crore versus Rs. 943.8 crore, up 14.6%. Domestic growth was 3.2% in Q3 and 8.8% in 9M FY25; EBITDA was 31.3% of sales in Q3. Managing Director and CEO Prabha Narasimhan said the quarter saw relatively soft demand, particularly in urban markets, and a heightened competitive landscape, but toothpaste delivered mid-single digit intrinsic volume growth and the premium portfolio showed positive momentum. Written by an AI model (claude-haiku-5-5) from the filing's first pages; it can be wrong - the filing is the source. | NSE copy |
| 28 Jan 2025 | board outcome Results | Colgate Palmolive (India) Limited has informed the Exchange regarding Board meeting held on January 28, 2025.AI summaryBoard outcome filing: the Board approved the unaudited financial results for the third quarter and nine months ended December 31, 2024, at a meeting held January 28, 2025 (2:22 p.m. to 3:45 p.m. IST). Q3 FY25 net sales were Rs. 1,452 crore, up 4.7% year-on-year; Q3 net profit after tax was Rs. 322.8 crore versus Rs. 330.1 crore a year earlier. Nine-month net sales were Rs. 4,547 crore, up 9.2% year-on-year; nine-month net profit after tax was Rs. 1,081.8 crore versus Rs. 943.8 crore, up 14.6%. Domestic growth was 3.2% in Q3 and 8.8% in 9M FY25, per the company's results release. Managing Director and CEO Prabha Narasimhan said management saw relatively soft demand, particularly in urban markets, and a heightened competitive landscape, while toothpaste reported mid-single digit intrinsic volume growth and premium portfolio momentum continued. Written by an AI model (claude-haiku-5-5) from the filing's first pages; it can be wrong - the filing is the source. | NSE copy |
| 03 Dec 2024 | transcript Dividend / buy-back, Guidance, Results | Colgate Palmolive (India) Limited has informed the Exchange about TranscriptAI summaryColgate-Palmolive (India) filed the transcript of its Investor/Analyst meet held on November 27, 2024, under Regulation 30 of the SEBI Listing Regulations. Managing Director and CEO Prabha Narasimhan said the company has grown above 5% for seven consecutive quarters, with the last three quarters at double-digit growth, and grew 1.6 times the average growth of the top 12 FMCG companies in FY23-24 and 2.4 times in the first half of the current financial year. Management said gross margin has been in the range of 68% to 70%, and that the recent step-up in EBITDA margin is likely to moderate and be rangebound. Management said urban toothpaste volume growth has slowed, while rural growth is plateauing, and it outlined four strategic pillars: growing the oral care category, premiumisation through science, leading growth in toothbrushes and devices, and diversifying into personal care. Management described the Oral Health Movement, including a free AI-powered dental screening campaign launched about two weeks before the meet, with 800 million packs carrying a QR code. Written by an AI model (claude-haiku-5-5) from the filing's first pages; it can be wrong - the filing is the source. | NSE copy |
| 27 Nov 2024 | presentation Results | Colgate Palmolive (India) Limited has informed the Exchange about Investor PresentationAI summaryColgate-Palmolive (India) filed the presentation for its Investor/Analyst Day held on November 27, 2024 at 10:30 a.m. (IST), per a cover letter from the Whole-time Director - Legal & Company Secretary. The pages provided are mainly section headings and a forward-looking statements disclaimer, with no detailed financial figures in the extracted text. Slides refer to domestic net sales growth (%) and topline growth, with a comparison against FMCG peers (CP India vs FMCG sector average for FY 23-24 and H1 24-25), though the numeric values are not legible in the extracted text. Slide headings describe performance as "Strong", "Robust" and "CONSISTENT", with the company stating it continues to win. Written by an AI model (claude-haiku-5-5) from the filing's first pages; it can be wrong - the filing is the source. | NSE copy |
The list of announcements the National Stock Exchange publishes for the company; each link opens the exchange's own copy. Ask Sensei searches these filings when a question names the company.